Login / Signup

Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients.

Irit AviviDavid H VesoleJulio Dávila-VallsLidia Usnarska-ZubkiewiczMagdalena Olszewska-SzopaVibor MilunovićBartłomiej BaumertBogumiła OsękowskaAnna KopińskaMassimo GentileBorja Puertas-MartinezPaweł RobakEdvan de Queiroz CrusoéLuis-Gerardo Rodríguez-LobatoMałgorzata GajewskaGergely VargaMichel DelforgeYael CohenAlessandro GozzettiCamila PeñaChaim ShustikGábor MikalaKlara ZalacH Denis AlexanderPeter BarthKatja WeiselJoaquín Martínez-LópezAnna Waszczuk-GajdaMateusz KrzystańskiArtur Jurczyszyn
Published in: Cancers (2023)
With the continuing improvement in OS, a higher proportion of MM patients might develop SPM. The OS following SPM diagnosis is poor; hence, frequent surveillance and early detection are imperative to improve outcomes.
Keyphrases
  • end stage renal disease
  • multiple myeloma
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • type diabetes
  • metabolic syndrome
  • skeletal muscle